Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Visualizer Designed as a Diagnostic Tool for DICOM Images

By MedImaging staff writers
Posted on 09 Jan 2008
The first of a series of diagnostic and theranostic tools has been developed for the detection and treatment of multiple cancer pathologies.

im3D-Medical Imaging Lab (Turin, Italy), a medical research that collaborates closely with medical, scientific, and clinical specialists worldwide to develop advanced medical imaging systems, reported that its new product, the DICOM (Digital Imaging and Communications in Medicine) visualizer, Visor, enhances the functionality of im3D's diagnostic workstation by grouping and displaying any number of radiologic exams for quick, single-source visualization. More...
Visor enables the radiologist to easily confront and compare exams, as well as relay exams to specialized computer-assisted detection (CAD) applications, thereby optimizing the overall workflow.

VISOR interfaces with im3D's flagship CAD-Colon diagnostic system, a commercially available interactive workstation, as well as with upstream picture archiving and communication systems (PACS). The DICOM visualizer represents an umbrella application that will help the radiologist efficiently manage computed tomography (CT), magnetic resonance imaging (MRI), and other radiology exams for use with im3D's CAD-based diagnostic tools. Visor is the first in a series of new systems that are being developed by im3D for breast, lung, and other cancer pathologies. Similar to CAD-Colon, im3D's new diagnostic systems are based on the company's proprietary software and are the result of clinical, scientific, and medical research.

im3D's systems feature advanced CAD technologies based on proprietary algorithms and methodologies developed by im3D. The company's flagship product, CAD-Colon, is a non-invasive system for the identification and prevention of colon cancer. CAD-Colon allows clinicians and radiologists to accurately detect polyps while they are small and easily removed, years before they become dangerous.

Im3D-Medical Imaging Lab was recently selected by Frost & Sullivan (Palo Alto, CA, USA) as the Entrepreneurial Company of the Year for its CAD-Colon interactive workstation, which was installed in healthcare facilities throughout Italy and within Massachusetts General Hospital (Boston, USA). im3D's products are CE- (Certified European Approval)-certified and commercially available within Europe, Canada, and the Middle East.


Related Links:
im3D-Medical Imaging Lab

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.